Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

HKG:6955 Revenue

Shandong Boan Biotechnology had revenue of 233.00M CNY in the half year ending June 30, 2026, a decrease of -35.80%. This brings the company's revenue in the last twelve months to 624.41M, down -17.49% year-over-year. In the year 2025, Shandong Boan Biotechnology had annual revenue of 784.82M with 8.06% growth.

• Revenue (ttm): 624.41M CNY
• Revenue Growth: -17.49%
• P/S Ratio: 2.10
• Revenue / Employee: 904.94K CNY
• Employees: 690
• Market Cap: 1.52B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	784.82M	58.51M	8.06%
Dec 31, 2024	726.32M	108.19M	17.50%
Dec 31, 2023	618.13M	102.17M	19.80%
Dec 31, 2022	515.96M	357.26M	225.11%
Dec 31, 2021	158.70M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 17, 2026

Data Sources Report a data error